These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
418 related items for PubMed ID: 10064002
41. Anticoagulant activity of an anti-beta 2-glycoprotein I antibody is dependent on the presence of beta 2-glycoprotein I. Matsuda J, Gohchi K, Tsukamoto M, Saitoh N, Asami K, Hashimoto M. Am J Hematol; 1993 Nov; 44(3):187-91. PubMed ID: 8213768 [Abstract] [Full Text] [Related]
42. Anticardiolipin antibodies block the inhibition by beta 2-glycoprotein I of the factor Xa generating activity of platelets. Shi W, Chong BH, Hogg PJ, Chesterman CN. Thromb Haemost; 1993 Aug 02; 70(2):342-5. PubMed ID: 8236146 [Abstract] [Full Text] [Related]
43. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant. Sakakura M, Wada H, Watanabe R, Mamamuro M, Okugawa Y, Nakasaki T, Nakase T, Wakita Y, Minamikawa K, Mori Y, Nshikawa M, Shiku H. Clin Appl Thromb Hemost; 2000 Jul 02; 6(3):144-50. PubMed ID: 10898274 [Abstract] [Full Text] [Related]
44. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis. Ishikura K, Wada H, Kamikura Y, Hattori K, Fukuzawa T, Yamada N, Nakamura M, Nobori T, Nakano T. Am J Hematol; 2004 Aug 02; 76(4):338-42. PubMed ID: 15282665 [Abstract] [Full Text] [Related]
45. Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombin. Rauch J, Tannenbaum M, Neville C, Fortin PR. Thromb Haemost; 1998 Dec 02; 80(6):936-41. PubMed ID: 9869164 [Abstract] [Full Text] [Related]
46. The contribution of anti-prothrombin-antibodies to lupus anticoagulant activity--discrimination between functional and non-functional anti-prothrombin-antibodies. Horbach DA, van Oort E, Derksen RH, de Groot PG. Thromb Haemost; 1998 Apr 02; 79(4):790-5. PubMed ID: 9569194 [Abstract] [Full Text] [Related]
47. Detection of lupus anticoagulant by means of dilute Russell's viper venom time is affected by oral anticoagulant therapy. Jouhikainen T. Blood Coagul Fibrinolysis; 1990 Dec 02; 1(6):627-32. PubMed ID: 2133242 [Abstract] [Full Text] [Related]
48. Lupus anticoagulants: diagnostic dilemma and clinical challenge. Triplett DA. Clin Lab Sci; 1997 Dec 02; 10(4):223-8. PubMed ID: 10169622 [Abstract] [Full Text] [Related]
49. Relationship of lupus anticoagulant, anticardiolipin, anti-beta2-GPI and anti-prothrombin autoantibodies with history of thrombosis in patients with the clinical suspicion of APA-syndrome. D'Angelo A, Safa O, Crippa L, Garlando A, Sabbadini MG, Vigano' D'Angelo S. Thromb Haemost; 1997 Aug 02; 78(2):967-8. PubMed ID: 9268210 [No Abstract] [Full Text] [Related]
50. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant. Yasuda S, Atsumi T, Matsuura E, Kaihara K, Yamamoto D, Ichikawa K, Koike T. Arthritis Rheum; 2005 Jan 02; 52(1):212-8. PubMed ID: 15641049 [Abstract] [Full Text] [Related]
51. Antiphospholipid antibody tests: spreading the net. Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA. Ann Rheum Dis; 2005 Nov 02; 64(11):1639-43. PubMed ID: 15817655 [Abstract] [Full Text] [Related]
52. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome. Lopez D, Garcia-Valladares I, Palafox-Sanchez CA, De La Torre IG, Kobayashi K, Matsuura E, Lopez LR. Am J Clin Pathol; 2004 Mar 02; 121(3):426-36. PubMed ID: 15023048 [Abstract] [Full Text] [Related]
54. Anti-beta2 glycoprotein 1 and the anti-phospholipid syndrome. Keane PA, Ravikumar K, O'shea SI, Cleary PE. Am J Ophthalmol; 2006 Oct 02; 142(4):701-2. PubMed ID: 17011877 [Abstract] [Full Text] [Related]
55. Beta-2-glycoprotein I dependent lupus anticoagulants form stable bivalent antibody beta-2-glycoprotein I complexes on phospholipid surfaces. Arnout J, Wittevrongel C, Vanrusselt M, Hoylaerts M, Vermylen J. Thromb Haemost; 1998 Jan 02; 79(1):79-86. PubMed ID: 9459328 [Abstract] [Full Text] [Related]
56. Antibodies against oxidized phospholipids in laboratory tests exploring lupus anti-coagulant activity. Rolla R, Vidali M, Serino R, Pergolini P, Albano E, Bellomo G. Clin Exp Immunol; 2007 Jul 02; 149(1):63-9. PubMed ID: 17488295 [Abstract] [Full Text] [Related]
57. The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile. Galli M, Finazzi G, Norbis F, Marziali S, Marchioli R, Barbui T. Thromb Haemost; 1999 May 02; 81(5):695-700. PubMed ID: 10365739 [Abstract] [Full Text] [Related]
58. Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part II--Lupus anticoagulant. Favaloro EJ, Bonar R, Marsden K. Semin Thromb Hemost; 2012 Jun 02; 38(4):404-11. PubMed ID: 22565408 [Abstract] [Full Text] [Related]
59. Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma. Bairey O, Blickstein D, Monselise Y, Lahav J, Stark P, Prokocimer M, Nativ HM, Kirgner I, Pazgal I, Shaklai M. Eur J Haematol; 2006 May 02; 76(5):384-91. PubMed ID: 16466368 [Abstract] [Full Text] [Related]
60. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation. Jennings I, Kitchen S, Woods TA, Preston FE, Greaves M. Thromb Haemost; 1997 May 02; 77(5):934-7. PubMed ID: 9184405 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]